Daily TMZ clinical trials

Daily Temozolomide for Elderly Patients With Unmethylated MGMT- Promoter Newly Diagnosed GliOblatoma

This study looks at a new way to give an existing chemotherapy, Temozolomide, to older patients with a specific type of aggressive brain cancer called glioblastoma. The aim is to see if this modified treatment can help slow the disease and improve survival when standard chemotherapy might not work as well.